217 related articles for article (PubMed ID: 23958217)
21. [Adjuvant and palliative therapy of melanoma. Current status].
Tilgen W
Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
[TBL] [Abstract][Full Text] [Related]
22. [After excision of primary stage I cutaneous melanoma, is an initial evaluation necessary?].
Richard-Lallemand MA
Ann Dermatol Venereol; 1995; 122(5):349-59. PubMed ID: 8572478
[No Abstract] [Full Text] [Related]
23. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
24. [Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous malignant melanoma. Consensus statement of the Network of Catalan and Balearic Melanoma Centers].
Mangas C; Paradelo C; Puig S; Gallardo F; Marcoval J; Azon A; Bartralot R; Bel S; Bigatà X; Curcó N; Dalmau J; del Pozo LJ; Ferrándiz C; Formigón M; González A; Just M; Llambrich A; Llistosella E; Malvehy J; Martí RM; Nogués ME; Pedragosa R; Rocamora V; Sàbat M; Salleras M
Actas Dermosifiliogr; 2010 Mar; 101(2):129-42. PubMed ID: 20223155
[TBL] [Abstract][Full Text] [Related]
25. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous melanoma: a model to study cancer metastasis.
Leong SP; Gershenwald JE; Soong SJ; Schadendorf D; Tarhini AA; Agarwala S; Hauschild A; Soon CW; Daud A; Kashani-Sabet M
J Surg Oncol; 2011 May; 103(6):538-49. PubMed ID: 21480247
[TBL] [Abstract][Full Text] [Related]
27. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
28. Melanoma: the management of local recurrence and in-transit metastasis.
Couture J
Can J Surg; 1982 Nov; 25(6):698-700. PubMed ID: 7139431
[TBL] [Abstract][Full Text] [Related]
29. Malignant melanoma: early detection and treatment.
Koh HK; Rogers GS
Prim Care; 1989 Sep; 16(3):685-94. PubMed ID: 2678177
[TBL] [Abstract][Full Text] [Related]
30. [The prognosis of patients with level V melanomas of the extremities].
Krüger I; Ghussen F; Groth W
Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis and lymphangiogenesis of skin cancers.
Dadras SS; Detmar M
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of cutaneous melanoma].
Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
[TBL] [Abstract][Full Text] [Related]
33. Treatment options for brain metastases from melanoma.
McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC
Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051
[TBL] [Abstract][Full Text] [Related]
34. [Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].
Sassolas B; Mourrégot A; Thariat J; Tiffet O; Dygai-Cochet I; Mirabel X; Truc G; Cupissol D; Modiano P; Combemale P; Bedane C; Derrey S; Lamant L; Lubrano V; Siegrist S; Rougé-Bugat MÈ; Mazeau-Woynar V; Verdoni L; Planchamp F; Leccia MT
Bull Cancer; 2014 Jan; 101(1):9-16. PubMed ID: 24369290
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment protocols of cutaneous melanoma: latest approach 2010.
Petrescu I; Condrea C; Alexandru A; Dumitrescu D; Simion G; Severin E; Albu C; Albu D
Chirurgia (Bucur); 2010; 105(5):637-43. PubMed ID: 21141087
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous melanoma: detecting it earlier, weighing management options.
Lane JE; Dalton RR; Sangueza OP
J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
[No Abstract] [Full Text] [Related]
37. Cutaneous melanoma in the elderly.
Testori A; Soteldo J; Sances D; Mazzarol G; Trifirò G; Zonta M; Rastrelli M; Schenone F; Verrecchia F
Melanoma Res; 2009 Jun; 19(3):125-34. PubMed ID: 19381113
[TBL] [Abstract][Full Text] [Related]
38. Precision medicine in oncology standard of care.
Adams L
Semin Oncol Nurs; 2014 May; 30(2):100-8. PubMed ID: 24794083
[TBL] [Abstract][Full Text] [Related]
39. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
40. The cutaneous manifestations of metastatic malignant melanoma.
Reed KB; Cook-Norris RH; Brewer JD
Int J Dermatol; 2012 Mar; 51(3):243-9. PubMed ID: 22348556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
